David Morrow to Cognitive Dysfunction
This is a "connection" page, showing publications David Morrow has written about Cognitive Dysfunction.
Connection Strength
0.080
-
Phase IIb Trial of an a7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence. J Clin Psychopharmacol. 2018 Aug; 38(4):307-316.
Score: 0.080